Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Ondansetron
BRIGHT MINDS BIOSCIENCES INC.
Opioid Withdrawal
1 trial -
Open Placebo
BRIGHT MINDS BIOSCIENCES INC.
Acute Pain
1 trial -
Oral carbohydrate (Outfast)
The First People's Hospital of Lianyungang
Gastrointestinal Surgery
1 trial -
Oral microbiota
Hospital Authority, Hong Kong
Dry Eye Syndrome
1 trial -
Oral supplementation of vitamin D
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Social Behavior
1 trial -
Oxytocin
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
PCSK9 inhibitor
The First People's Hospital of Lianyungang
Intracranial Artery Stenosis
1 trial -
PCSK9 inhibitor (PCSK9i)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
PD1-BCMA-CART
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
POHIM-RT
Samsung Bioepis NL B.V.
Cervix Cancer
1 trial -
PRDR
Beam Therapeutics
Glioma
1 trial -
PROGRAM
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Obesity
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
The First People's Hospital of Lianyungang
Breast Cancers
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancers
1 trial -
Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar
The University of Hong Kong
Recurrent Ovarian Carcinoma
1 trial -
Paroxetine
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
1 trial -
Peak value anti-Xa
The First People's Hospital of Lianyungang
Venous Thromboembolism
1 trial -
Peanuts
United Therapeutics Europe Ltd
Prediabetes
1 trial -
Peginterferon Ξ±-2b injection
The First People's Hospital of Lianyungang
Condylomata Acuminata
1 trial -
Peginterferon Ξ±-2b plus an anti-PD-1
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial -
Percutaneous Transluminal Angioplasty (PTA)
Blackmores Limited
Peripheral Artery Disease
1 trial -
Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter
Blackmores Limited
Peripheral Artery Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources